Back to Search Start Over

Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).

Authors :
Boutari, Chrysoula
Rizos, Christos V.
Doumas, Michalis
Liamis, George
Skoumas, Ioannis
Rallidis, Loukianos
Garoufi, Anastasia
Kolovou, Genovefa
Tziomalos, Konstantinos
Skalidis, Emmanouil
Kotsis, Vasileios
Sfikas, George
Lambadiari, Vaia
Anagnostis, Panagiotis
Bilianou, Eleni
Anastasiou, Georgia
Koutagiar, Iosif
Kiouri, Estela
Attilakos, Achilleas
Kolovou, Vana
Source :
Pharmaceuticals (14248247); Jan2023, Vol. 16 Issue 1, p44, 14p
Publication Year :
2023

Abstract

Familial hypercholesterolemia (FH) and type 2 diabetes mellitus (T2DM) are both associated with a high risk of atherosclerotic cardiovascular disease (ASCVD). Little is known about the prevalence of T2DM and its association with ASCVD risk in FH patients. This was a cross-sectional analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) including adults with FH (n = 1719, mean age 51.3 ± 14.6 years). Of FH patients, 7.2% had a diagnosis of T2DM. The prevalence of ASCVD, coronary artery disease (CAD), and stroke was higher among subjects with T2DM compared with those without (55.3% vs. 23.3%, 48.8% vs. 20.7%, 8.3% vs. 2.7%, respectively, p < 0.001). When adjusted for age, systolic blood pressure, smoking, body mass index, hypertension, waist circumference, triglyceride levels, high-density lipoprotein cholesterol levels, and gender, T2DM was significantly associated with prevalent ASCVD [OR 2.0 (95% CI 1.2–3.3), p = 0.004]. FH patients with T2DM were more likely to have undergone coronary revascularization than those without (14.2% vs. 4.5% for coronary artery bypass graft, and 23.9% vs. 11.5% for percutaneous coronary intervention, p < 0.001). T2DM is associated with an increased risk for prevalent ASCVD in subjects with FH. This may have implications for risk stratification and treatment intensity in these patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14248247
Volume :
16
Issue :
1
Database :
Complementary Index
Journal :
Pharmaceuticals (14248247)
Publication Type :
Academic Journal
Accession number :
161476144
Full Text :
https://doi.org/10.3390/ph16010044